Thrivous Upgrades Clarity Daily Nootropic with Synapsa

23 May 2018 (22 May 2018)

Thrivous Clarity Daily Nootropic Formula 3

Orem UT – Thrivous, the human enhancement company, has launched Formula 3 of Clarity Daily Nootropic. Formula 3 incorporates Synapsa, a standardized and patented form of bacopa monnieri that has been the subject of more than 30 years of clinical study for memory support.

While most cognitive health supplements focus on the issue of cognitive decline – mainly in an aging population – the studies behind Synapsa focus on ‘peak cognitive performance’ outcomes that offer benefits for a much broader public. In six double-blind, placebo-controlled clinical studies, healthy adults using Synapsa showed significantly improved performance in areas such as visual processing, learning rate, working memory, information retention and mental performance in cognitively demanding environments versus a placebo regimen.

"Thrivous is dedicated to helping our customers access the most effective cognitive enhancement available in the real world," said Lincoln Cannon, CEO at Thrivous. "Tomorrow, that may be something out of science fiction. Today, it's nootropics like Clarity, which we formulate based on extensive analysis of decades of clinical research from scientists around the world. With Synapsa, we're improving the formula, and extending the product value for our customers."

Formula 3 of Clarity Daily Nootropic incorporates zinc picolinate, a more bioavailable form of zinc for mood support. It incorporates higher doses of several B Vitamins (B1, B2, B3, B5, and B6) in bioavailable and neuroavailable forms to support healthy brain function. And it continues to include rhodiola rosea to enhance focus, energy, and mood.

Clarity Daily Nootropic contains only nutrients and doses based on high levels of evidence for safety and efficacy from multiple clinical studies on humans — no experimental substances and no placebo dust. Because science is never finished, Thrivous monitors and analyzes new studies, consults with its advisor board of physicians and scientists, and seeks continuously to improve all of its supplement formulas.

Clarity Daily Nootropic passes through multiple rounds of rigorous quality control. Suppliers subject each nutrient to identity, potency, microbial, heavy metals, and other testing as appropriate prior to manufacturing. Manufacturing follows strict GMP regulation from the FDA in audited and certified facilities, verifying the test results of suppliers, and subjecting combined nutrients to additional testing.

Clarity Daily Nootropic has an open source formula, clearly identifying all nutrients and doses — no hiding behind secret proprietary blends. Thrivous publishes a certificate of analysis and quality for each of its supplements, transparently revealing all test results from suppliers and manufacturing. And it also publishes a summary of clinical studies for each supplement, sharing the science behind its formulas.

Product Webpage

https://thrivous.com/products/clarity-daily-nootropic

Summary of Clinical Studies

https://cloud.thrivous.com/downloads/socs-clarity-daily-nootropic.pdf

Certificate of Analysis and Quality

https://cloud.thrivous.com/downloads/coaq-clarity-daily-nootropic.pdf

About Thrivous

Thrivous is the human enhancement company. Its mission is to help people access technology with the greatest potential to improve their brains and bodies. In pursuit of that mission, it develops and distributes nootropics to enhance cognition and geroprotectors to support healthy aging, with open-source formulas and evidence-based dosages of natural ingredients. For more information, contact support@thrivous.com.

About Synapsa

Synapsa is a trademark of Soho Flordis International Pty Ltd., exclusively licensed in the United States to PLT Health Solutions, Inc.